Summary
43 / 100 · Bulios Score
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- Analysts expect revenue to fall by 5.7% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 8.2% a year over 5 years. Over the last 3 years it grew by 6.7% a year. For the next fiscal year analysts expect revenue to fall by 5.7%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $112.6M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 8
- Hold 22
- Sell 7
Today's price within the analysts' price targets
The average target of $3.92 is 32% below today's price. 22% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2023By product
- Testing Revenue 100%
By region
- UNITED STATES 93%
- Non-US 6.9%
Testing Revenue brings in 100% of revenue.
Segments in detail